Price:$21.95 Free Shipping + Save up to 20%! Learn
more
References
AREDS Report No. 8. A randomized, placebo-controlled clinical trial
of high-dose supplementation with vitamins C and E, beta-carotene,
and zinc
for age-related macular degeneration and vision loss. Arch Ophthalmol
119: 1417-1436, 2001.
Beatty S, et al. The role of oxidative stress in the pathogenesis
of age-related macular degeneration. Surv Ophthalmol 45:115-134, 2000.
Ferslew KE, Acuff RV, Daigneault EA, Woolley TW, and Stanton PE.
Pharmacokinetics and bioavailability of
the RRR and all racemic stereoisomers of alpha-tocopherol in humans
after single oral administration. J Clin Pharmacol 33: 84-88, 1993.
Traber MG, Elsner A, and Brigelius-Flohe R. Synthetic as compared
with natural vitamin E is preferentially excreted as alpha-CEHC in
human urine: studies using deuterated alpha-tocopheryl acetates. FEBS
Letters 437: 145-148, 1998.
Burton GW, Traber MG, Acuff R, Walters DN, Kayden H, Hughes L,
and Ingold KU. Human plasma and tissue alpha-tocopherol concentrations
in response to supplementation with deuterated natural and synthetic
vitamin E. Am J Clin Nutr 67: 669-684, 1998.
Weinstein SJ. Serum alpha-tocopherol and gamma-tocopherol in relation
to prostate cancer risk in a prospective study. J Natl Cancer Inst.
97: 396-399, 2005.
Morris MC, et al. Relation of the tocopherol forms to incident
Alzheimer disease and to cognitive change. A J Clinc Nutr 81: 508-14,
2005.14. Stahl. W. Review: Macular carotenoids: lutein and zeaxanthin.
Dev Ophthalmol 38: 70-88, 2005.
Grahn BH, et al. Review: zinc
and the eye. J Am Coll Nutr 20: 106-118, 2001.
Landrum JT, et al. Lutein, zeaxanthin and the macular pigment.
Arch Biochem Biophys 385: 28-40, 2001.
Beatty S, et al. Macular pigment and risk for age-related macular
degeneration in subjects from a Northern European population. Invest
Ophthalmol Vis Sci 42: 439-446, 2001.
Bone RA, et al. Macular pigment in donor eyes with and without
AMD: a case-control study. Invest Ophthalmol Vis Sci 42: 235-240,
2001.
Johnson EJ, et al. Relation among serum and tissue concentrations
of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr
71: 1555-1562, 2000.
Berendschot TT, et al. Influence of lutein supplementation on
macular pigment, assessed with two objective techniques. Invest Ophthalmol
Vis Sci 41: 3322-3326, 2000.
Richer S et al. Double-masked, placebo-controlled, randomized
trial of lutein and antioxidant supplementation in the intervention
of atrophic age-related macular degeneration: the Veterans LAST study
(Lutein Antioxidant Supplementation Trial). Optometry 75: 216-230,
2004.
Humphries JM et al. Distribution of lutein, zeaxanthin, and related
geometrical isomers in fruit, vegetables, wheat, and pasta products.
J Agric Food Chem 51: 1322-1327, 2003.
Castenmiller JJ, et al. The food matrix of spinach is a limiting
factor in determining the bioavailability of beta- carotene and to
a lesser extent of lutein in humans. J Nutr 129: 349-355, 1999.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Return
to Top